— Know what they know.
Not Investment Advice

CURX NASDAQ

Curanex Pharmaceuticals Inc Common Stock
1W: -9.2% 1M: -29.9% 3M: -58.1% YTD: -50.3%
$0.20
+0.01 (+8.20%)
After Hours: $0.17 (-0.03, -13.11%)
Weekly Expected Move ±8.8%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 31 · $5.6M mcap · 8M float · 1.17% daily turnover · Short 37% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$5.6M
52W Range0.179-9.18
Volume57,375
Avg Volume88,056
Beta-2.85
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOJun Liu
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2025-08-26
2 Jericho Plaza
Jericho, NY 11753
US
718 673 6078
About Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.

Recent Insider Trades

NameTypeSharesPriceDate
Xie Liqin 0 2025-08-25
Hsu Helen Hong 0 2025-08-25
Zhong Huijuan 0 2025-08-25
Yan Yong 0 2025-08-25
Liu Jun 0 2025-08-25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms